Sarepta Therapeutics Inc (NASDAQ: SRPT) – Not A Clear Buying Opportunity?
Sarepta Therapeutics Inc (SRPT) concluded trading on Wednesday at a closing price of $62.47, with 3.77 million shares of worth about $235.74 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -49.98% during that period and on April 03, 2025 the price saw a […]
Sarepta Therapeutics Inc (NASDAQ: SRPT): The Best-Of-Breed For Investing?
Currently, there are 96.90M common shares owned by the public and among those 91.14M shares have been available to trade. The company’s stock has a 5-day price change of -26.98% and -40.92% over the past three months. SRPT shares are trading -39.52% year to date (YTD), with the 12-month market performance down to -40.58% lower. […]
Sarepta Therapeutics Inc (NASDAQ: SRPT): The Best-Of-Breed For Investing?
The Vanguard Group, Inc. recently announced the acquisition of new stake in Sarepta Therapeutics Inc (NASDAQ:SRPT). The institutional investor has increased its shareholding in the Healthcare company by 0.46% to 8.45 million shares with purchase of 38383.0 shares. This fresh investment now brings its stake to 9.03% valued currently at $686.45 million. In addition, Janus […]
